Contact Us

Head Office
Protox Therapeutics Corp.
1258 Prospect Street
La Jolla, California 92037 USA
t: 858.777.1760
f: 858.412.5693
info@protoxtherapeutics.com

Map of Location

For Business Development inquiries, contact Annica Martensson at:
amartensson@protoxtherapeutics.com

For Investor inquiries, contact James Beesley at:
ir@protoxtherapeutics.com

For Clinical Trial inquiries, contact Richard Yocum at:
ryocum@protoxtherapeutics.com

For all other inquiries,
info@protoxtherapeutics.com

Email Update
To receive the latest information about developments at Protox,
sign up here to be included on our email list.

NAME:         
EMAIL:  

What's New

December 28, 2011
Protox Therapeutics Announces Closing of Additional CDN $8.3M Investment By Warburg Pincus

December 23, 2011
Protox Therapeutics Announces Additional CDN $8.3M Investment by Warburg Pincus

December 22, 2011
Protox Completes Dosing of Second Cohort of Patients in Transrectal Study

 

 

 

Events

November 17, 2010
- 11:15 am ET
Protox Presents at Dundee Emerging Growth Conference

 

Stock Quote

LAST TRADE:$0.35
TRADE TIME:3:49PM EST
CHANGE:$0.02 (6.06%)
PREV CLOSE: $0.33
OPEN:$0.335
BID:$0.34
ASK:$0.35